Search

Author/Creator Shabason, Jacob

1. CTIM-35. A PHASE II STUDY OF GITR AGONIST INCAGN01876 AND PD-1 INHIBITOR RETIFANLIMAB IN COMBINATION WITH STEREOTACTIC RADIOTHERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (14th November 2022)

Authors:
Bagley, Stephen; Shabason, Jacob; Mathew, Divij; Kothari, Shawn; Oldridge, Derek; Desai, Arati; Lustig, Robert; Kurtz, Goldie; Alonso-Basanta, Michelle; Chen, Kan; Long, Qi; Harsch, Jessica; Salman, Muhammad; Fernandez, Peter; Monsour, Maikel; Prior, Timothy; Maloney, Eileen; MacMurtrie, Eileen; ...
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. (September 2021)

Authors:
Arscott, William T.; Nead, Kevin T.; Bear, Adham; Venigalla, Sriram; Shabason, Jacob; Lukens, John N.; Plastaras, John P.; Wojcieszynski, Andrzej; Metz, James; O'Hara, Mark; Reiss, Kim A.; Teitelbaum, Ursina; Loaiza-Bonilla, Arturo; Drebin, Jeffrey; Lee, Major K.; Shroff, Stuti G.; Ben-Josef, Edgar
Journal:
American journal of clinical oncology
Issue:
Volume 44:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗